🎗️ OncologyInjection (IV)
Lunsumio
Mosunetuzumab
CD20-CD3 bispecific T-cell engager for relapsed/refractory follicular lymphoma.
Form
Injection (IV)
Uses
1
Side effects
6
Category
Oncology
01
What is Lunsumio used for?
- Relapsed/refractory follicular lymphoma
02
Mosunetuzumab side effects
The following side effects have been reported for Mosunetuzumab. Their order does not indicate how often an effect occurs.
Cytokine release syndrome
Fever
Fatigue
Rash
Nausea
Infections
03
Mosunetuzumab warnings & precautions
- Black box: CRS and neurologic toxicity
- REMS program
- Serious infections
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Lunsumio in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.